 "iNCOVACC")
Bharat Biotech on Thursday launched the country’s first intra-nasal Covid vaccine iNCOVACC for a primary as well as heterologous (mix-and-match) booster dose in India.
It is the world’s first nasal Covid-19 vaccine that has been approved both as a primary two-dose regimen, and as a heterologous booster after two doses of Covishield or Covaxin.
The vaccine’s roll-out is expected to begin in private hospitals that have placed advance orders.
iNCOVACC is priced at Rs 325 per dose for large volumes procured by states and the Centre. In the private market, the vaccine is priced at Rs 800 per dose.
The
